142 related articles for article (PubMed ID: 33585224)
1. Serum-Based KRAS
Kim JS; Bae GE; Kim SH; Choi MK; Yeo MK
Front Oncol; 2020; 10():604772. PubMed ID: 33585224
[TBL] [Abstract][Full Text] [Related]
2. Detection of
Michaelidou K; Koutoulaki C; Mavridis K; Vorrias E; Papadaki MA; Koutsopoulos AV; Mavroudis D; Agelaki S
Cells; 2020 Nov; 9(11):. PubMed ID: 33233668
[No Abstract] [Full Text] [Related]
3. Identification of a Clinical Cutoff Value for Multiplex KRAS
Lee KH; Lee TH; Choi MK; Kwon IS; Bae GE; Yeo MK
J Clin Med; 2020 Jul; 9(7):. PubMed ID: 32708359
[TBL] [Abstract][Full Text] [Related]
4. Mutation-Enrichment Next-Generation Sequencing for Quantitative Detection of
Fujii T; Barzi A; Sartore-Bianchi A; Cassingena A; Siravegna G; Karp DD; Piha-Paul SA; Subbiah V; Tsimberidou AM; Huang HJ; Veronese S; Di Nicolantonio F; Pingle S; Vibat CRT; Hancock S; Berz D; Melnikova VO; Erlander MG; Luthra R; Kopetz ES; Meric-Bernstam F; Siena S; Lenz HJ; Bardelli A; Janku F
Clin Cancer Res; 2017 Jul; 23(14):3657-3666. PubMed ID: 28096270
[No Abstract] [Full Text] [Related]
5. Multiplex KRASG12/G13 mutation testing of unamplified cell-free DNA from the plasma of patients with advanced cancers using droplet digital polymerase chain reaction.
Janku F; Huang HJ; Fujii T; Shelton DN; Madwani K; Fu S; Tsimberidou AM; Piha-Paul SA; Wheler JJ; Zinner RG; Naing A; Hong DS; Karp DD; Cabrilo G; Kopetz ES; Subbiah V; Luthra R; Kee BK; Eng C; Morris VK; Karlin-Neumann GA; Meric-Bernstam F
Ann Oncol; 2017 Mar; 28(3):642-650. PubMed ID: 27993791
[TBL] [Abstract][Full Text] [Related]
6.
van 't Erve I; Wesdorp NJ; Medina JE; Ferreira L; Leal A; Huiskens J; Bolhuis K; van Waesberghe JTM; Swijnenburg RJ; van den Broek D; Velculescu VE; Kazemier G; Punt CJA; Meijer GA; Fijneman RJA
JCO Precis Oncol; 2021; 5():. PubMed ID: 34820593
[TBL] [Abstract][Full Text] [Related]
7. KRAS mutation testing in colorectal cancer: comparison of the results obtained using 3 different methods for the analysis of codons G12 and G13.
Bihl MP; Hoeller S; Andreozzi MC; Foerster A; Rufle A; Tornillo L; Terracciano L
Diagn Mol Pathol; 2012 Mar; 21(1):14-23. PubMed ID: 22306671
[TBL] [Abstract][Full Text] [Related]
8. Clinical Evaluation of IntelliPlex™ KRAS G12/13 Mutation Kit for Detection of KRAS Mutations in Codon 12 and 13: A Novel Multiplex Approach.
Chen CL; Chen CK; Ho CL; Chi WM; Yeh CH; Hu SP; Friebe P; Palmer S; Huang CS
Mol Diagn Ther; 2019 Oct; 23(5):645-656. PubMed ID: 31347028
[TBL] [Abstract][Full Text] [Related]
9. High MACC1 expression in combination with mutated KRAS G13 indicates poor survival of colorectal cancer patients.
Ilm K; Kemmner W; Osterland M; Burock S; Koch G; Herrmann P; Schlag PM; Stein U
Mol Cancer; 2015 Feb; 14():38. PubMed ID: 25742883
[TBL] [Abstract][Full Text] [Related]
10. RAS/RAF mutations in tumor samples and cell-free DNA from plasma and bone marrow aspirates in multiple myeloma patients.
Li Q; Huang HJ; Ma J; Wang Y; Cao Z; Karlin-Neumann G; Janku F; Liu Z
J Cancer; 2020; 11(12):3543-3550. PubMed ID: 32284750
[No Abstract] [Full Text] [Related]
11. The Level of Preoperative Plasma KRAS Mutations and CEA Predict Survival of Patients Undergoing Surgery for Colorectal Cancer Liver Metastases.
Polivka J; Windrichova J; Pesta M; Houfkova K; Rezackova H; Macanova T; Vycital O; Kucera R; Slouka D; Topolcan O
Cancers (Basel); 2020 Aug; 12(9):. PubMed ID: 32867151
[TBL] [Abstract][Full Text] [Related]
12. Multivariate Risk Analysis of RAS, BRAF and EGFR Mutations Allelic Frequency and Coexistence as Colorectal Cancer Predictive Biomarkers.
Ionescu A; Bilteanu L; Geicu OI; Iordache F; Stanca L; Pisoschi AM; Miron A; Serban AI; Calu V
Cancers (Basel); 2022 Jun; 14(11):. PubMed ID: 35681771
[TBL] [Abstract][Full Text] [Related]
13. Droplet digital PCR revealed high concordance between primary tumors and lymph node metastases in multiplex screening of KRAS mutations in colorectal cancer.
Vanova B; Kalman M; Jasek K; Kasubova I; Burjanivova T; Farkasova A; Kruzliak P; Busselberg D; Plank L; Lasabova Z
Clin Exp Med; 2019 May; 19(2):219-224. PubMed ID: 30661213
[TBL] [Abstract][Full Text] [Related]
14. KRAS mutation status concordance between the primary tumor and the corresponding metastasis in patients with rectal cancer.
Jo P; Bernhardt M; Nietert M; König A; Azizian A; Schirmer MA; Grade M; Kitz J; Reuter-Jessen K; Ghadimi M; Ströbel P; Schildhaus HU; Gaedcke J
PLoS One; 2020; 15(10):e0239806. PubMed ID: 33002027
[TBL] [Abstract][Full Text] [Related]
15. Detection of mutations in circulating cell-free DNA in relation to disease stage in colorectal cancer.
Liebs S; Keilholz U; Kehler I; Schweiger C; Haybäck J; Nonnenmacher A
Cancer Med; 2019 Jul; 8(8):3761-3769. PubMed ID: 31134762
[TBL] [Abstract][Full Text] [Related]
16. High Concordance and Negative Prognostic Impact of RAS/BRAF/PIK3CA Mutations in Multiple Resected Colorectal Liver Metastases.
Brunsell TH; Sveen A; Bjørnbeth BA; Røsok BI; Danielsen SA; Brudvik KW; Berg KCG; Johannessen B; Cengija V; Abildgaard A; Guren MG; Nesbakken A; Lothe RA
Clin Colorectal Cancer; 2020 Mar; 19(1):e26-e47. PubMed ID: 31982351
[TBL] [Abstract][Full Text] [Related]
17. Measuring KRAS Mutations in Circulating Tumor DNA by Droplet Digital PCR and Next-Generation Sequencing.
Demuth C; Spindler KG; Johansen JS; Pallisgaard N; Nielsen D; Hogdall E; Vittrup B; Sorensen BS
Transl Oncol; 2018 Oct; 11(5):1220-1224. PubMed ID: 30086420
[TBL] [Abstract][Full Text] [Related]
18. High concordance of mutation patterns in 10 common mutated genes between tumor tissue and cell-free DNA in metastatic colorectal cancer.
Lan YT; Chang SC; Lin PC; Lin CH; Liang WY; Chen WS; Jiang JK; Yang SH; Lin JK
Am J Cancer Res; 2021; 11(5):2228-2237. PubMed ID: 34094680
[TBL] [Abstract][Full Text] [Related]
19. Comparison of KRAS Mutation Assessment in Tumor DNA and Circulating Free DNA in Plasma and Serum Samples.
Morgan SR; Whiteley J; Donald E; Smith J; Eisenberg MT; Kallam E; Kam-Morgan L
Clin Med Insights Pathol; 2012; 5():15-22. PubMed ID: 22661904
[TBL] [Abstract][Full Text] [Related]
20. KRAS genotypic changes of circulating tumor cells during treatment of patients with metastatic colorectal cancer.
Kalikaki A; Politaki H; Souglakos J; Apostolaki S; Papadimitraki E; Georgoulia N; Tzardi M; Mavroudis D; Georgoulias V; Voutsina A
PLoS One; 2014; 9(8):e104902. PubMed ID: 25137394
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
